Biotech / Pharma
Precision Neuroscience
Biotech / Pharma
Precision Neuroscience, a brain-interface startup with Neuralink alumni, raised $250M in a Series D led by Pershing Square to advance clinical trials, FDA approvals, and commercialization of its surface-mounted brain implant.
Founded
Region
Investors
People